Matches in Wikidata for { <http://www.wikidata.org/entity/Q94957551> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q94957551 description "article scientifique publié en 2020" @default.
- Q94957551 description "artykuł naukowy opublikowany 17 maja 2020" @default.
- Q94957551 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q94957551 description "scientific article published on 17 May 2020" @default.
- Q94957551 description "wetenschappelijk artikel" @default.
- Q94957551 description "наукова стаття, опублікована 17 травня 2020" @default.
- Q94957551 name "Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluation" @default.
- Q94957551 name "Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluation" @default.
- Q94957551 type Item @default.
- Q94957551 label "Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluation" @default.
- Q94957551 label "Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluation" @default.
- Q94957551 prefLabel "Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluation" @default.
- Q94957551 prefLabel "Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluation" @default.
- Q94957551 P1433 Q94957551-77DC16C6-669F-475A-99CE-34B479E43180 @default.
- Q94957551 P1476 Q94957551-260CF50D-8024-4356-AB39-FD9EBC3642F5 @default.
- Q94957551 P2093 Q94957551-14369D6A-038E-4A02-8BA2-57AAF8D8D59B @default.
- Q94957551 P2093 Q94957551-8F9D215D-39B4-4A07-A092-84DEEE9639FD @default.
- Q94957551 P2093 Q94957551-B1756270-7DF6-4775-8E0F-BDB2CE42AD3E @default.
- Q94957551 P304 Q94957551-D70EE5F3-F61A-449A-8E80-7E47E10003DF @default.
- Q94957551 P31 Q94957551-5D9BA4DA-74F9-4EBA-89C0-029065D6CB8D @default.
- Q94957551 P31 Q94957551-E9D94504-7D7A-447E-B8B6-FA368EB937D6 @default.
- Q94957551 P356 Q94957551-F3FE362B-E364-497B-AC2D-9FED035EA929 @default.
- Q94957551 P433 Q94957551-A1B0CC53-335F-441E-B29D-5CAF4F126AAC @default.
- Q94957551 P478 Q94957551-7A0D7F5C-2339-4BB3-BF9D-513FF4962559 @default.
- Q94957551 P577 Q94957551-AADC866E-7C66-40E1-9DFE-8E288751582F @default.
- Q94957551 P698 Q94957551-4C2A2952-A001-409C-B4E1-CAD9F2BFC809 @default.
- Q94957551 P356 S12249-020-01694-0 @default.
- Q94957551 P698 32419084 @default.
- Q94957551 P1433 Q15750612 @default.
- Q94957551 P1476 "Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluation" @default.
- Q94957551 P2093 "Kifayat Ullah Khan" @default.
- Q94957551 P2093 "Muhammad Usman Minhas" @default.
- Q94957551 P2093 "Naveed Akhtar" @default.
- Q94957551 P304 "141" @default.
- Q94957551 P31 Q13442814 @default.
- Q94957551 P31 Q45182324 @default.
- Q94957551 P356 "10.1208/S12249-020-01694-0" @default.
- Q94957551 P433 "5" @default.
- Q94957551 P478 "21" @default.
- Q94957551 P577 "2020-05-17T00:00:00Z" @default.
- Q94957551 P698 "32419084" @default.